TMCI TREACE MEDICAL CONCEPTS, INC.

Nasdaq treace.com


$ 3.59 $ -0.86 (-19.41 %)    

Monday, 10-Nov-2025 19:37:10 EST
QQQ $ 623.82 $ 4.38 (0.71 %)
DIA $ 473.95 $ 1.94 (0.41 %)
SPY $ 681.69 $ 4.15 (0.61 %)
TLT $ 89.46 $ 0.06 (0.07 %)
GLD $ 380.15 $ 2.40 (0.64 %)
$ 3.56
$ 4.43
$ 3.50 x 72
$ 4.65 x 42
-- - --
$ 3.40 - $ 10.79
2,341,251
na
226.84M
$ 1.43
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-06-2025 09-30-2025 10-Q
2 08-07-2025 06-30-2025 10-Q
3 05-08-2025 03-31-2025 10-Q
4 02-27-2025 12-31-2024 10-K
5 11-05-2024 09-30-2024 10-Q
6 08-06-2024 06-30-2024 10-Q
7 05-07-2024 03-31-2024 10-Q
8 02-27-2024 12-31-2023 10-K
9 11-09-2023 09-30-2023 10-Q
10 08-09-2023 06-30-2023 10-Q
11 05-09-2023 03-31-2023 10-Q
12 03-08-2023 12-31-2022 10-K
13 11-09-2022 09-30-2022 10-Q
14 08-10-2022 06-30-2022 10-Q
15 05-06-2022 03-31-2022 10-Q
16 03-04-2022 12-31-2021 10-K
17 11-04-2021 09-30-2021 10-Q
18 08-05-2021 06-30-2021 10-Q
19 05-25-2021 03-31-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 truist-securities-reiterates-hold-on-treace-medical-concepts-lowers-price-target-to-4

Truist Securities analyst Richard Newitter reiterates Treace Medical Concepts (NASDAQ:TMCI) with a Hold and lowers the price...

 ubs-maintains-neutral-on-treace-medical-concepts-lowers-price-target-to-585

UBS analyst Danielle Antalffy maintains Treace Medical Concepts (NASDAQ:TMCI) with a Neutral and lowers the price target fro...

 jp-morgan-downgrades-treace-medical-concepts-to-underweight-lowers-price-target-to-5

JP Morgan analyst Lilia-Celine Lozada downgrades Treace Medical Concepts (NASDAQ:TMCI) from Neutral to Underweight and lower...

 btig-downgrades-treace-medical-concepts-to-neutral

BTIG analyst Ryan Zimmerman downgrades Treace Medical Concepts (NASDAQ:TMCI) from Buy to Neutral.

 treace-medical-concepts-lowers-fy2025-sales-guidance-from-224000m-230000m-to-211000m-213000m-vs-227083m-est

Treace Medical Concepts (NASDAQ:TMCI) lowers FY2025 sales outlook from $224.000 million-$230.000 million to $211.000 million-$2...

 treace-medical-concepts-q3-eps-026-beats-028-estimate-sales-50214m-beat-49732m-estimate

Treace Medical Concepts (NASDAQ:TMCI) reported quarterly losses of $(0.26) per share which beat the analyst consensus estimate ...

 truist-securities-maintains-hold-on-treace-medical-concepts-lowers-price-target-to-7

Truist Securities analyst Richard Newitter maintains Treace Medical Concepts (NASDAQ:TMCI) with a Hold and lowers the price ...

 truist-securities-maintains-hold-on-treace-medical-concepts-raises-price-target-to-8

Truist Securities analyst Richard Newitter maintains Treace Medical Concepts (NASDAQ:TMCI) with a Hold and raises the price ...

 ubs-maintains-neutral-on-treace-medical-concepts-lowers-price-target-to-65

UBS analyst Danielle Antalffy maintains Treace Medical Concepts (NASDAQ:TMCI) with a Neutral and lowers the price target fro...

 stifel-maintains-hold-on-treace-medical-concepts-lowers-price-target-to-6

Stifel analyst Rick Wise maintains Treace Medical Concepts (NASDAQ:TMCI) with a Hold and lowers the price target from $9 to $6.

 treace-medical-concepts-affirms-fy2025-sales-guidance-of-224000m-230000m-vs-227030m-est

Treace Medical Concepts (NASDAQ:TMCI) affirms FY2025 sales outlook from $224.000 million-$230.000 million to $224.000 million-$...

 treace-medical-concepts-q2-eps-028-beats-029-estimate-sales-47387m-beat-47077m-estimate

Treace Medical Concepts (NASDAQ:TMCI) reported quarterly losses of $(0.28) per share which beat the analyst consensus estimate ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION